Cargando…
Trends and Inpatient Outcomes of Venous Thromboembolism-Related Admissions in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
Background Patients with Philadelphia-negative myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (MF), have a significant risk of venous thromboembolism (VTE). We aim to determine the trends in annual rates of VTE-related...
Autores principales: | Katiyar, Vatsala, Uprety, Alok, Mendez-Hernandez, Andres, Fuentes, Harry E., Andrade, Xavier A., Zia, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637016/ https://www.ncbi.nlm.nih.gov/pubmed/31321378 http://dx.doi.org/10.1055/s-0039-1692988 |
Ejemplares similares
-
Philadelphia-negative chronic myeloproliferative neoplasms
por: Bittencourt, Rosane Isabel, et al.
Publicado: (2012) -
Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms
por: De Stefano, Valerio, et al.
Publicado: (2018) -
Circulating Endothelial Cells in Patients with Venous Thromboembolism and Myeloproliferative Neoplasms
por: Torres, Cláudia, et al.
Publicado: (2013) -
Molecular biology of Philadelphia-negative myeloproliferative neoplasms
por: Campregher, Paulo Vidal, et al.
Publicado: (2012) -
Inflammatory picture of Philadelphia-negative myeloproliferative neoplasms()
por: Pagnano, Katia Borgia Barbosa
Publicado: (2018)